文献速递神经肿瘤

谷氨酰胺回补是人脑膜瘤氨基酸生物合成所必需的

Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas.
PubMed 文献 · Neuro Oncol · 2022-01-01

研究对新鲜切除的脑膜瘤组织进行1H NMR代谢组学分析,并在5例患者来源脑膜瘤细胞中用13C/15N谷氨酰胺示踪检测谷氨酰胺代谢。结果显示丙氨酸、乳酸、谷氨酸、谷氨酰胺和甘氨酸仅在II级脑膜瘤中升高,其中丙氨酸和谷氨酰胺具统计学显著性(P≤.02);I级和II级脑膜瘤均活跃代谢谷氨酰胺生成丙氨酸和脯氨酸等关键碳中间体,GLS1抑制剂CB-839可有效下调谷氨酰胺代谢并减少脑膜瘤细胞增殖。

要点

  • 丙氨酸和谷氨酰胺/谷氨酸主要在II级脑膜瘤中升高。
  • I级脑膜瘤谷氨酰胺代谢较高,为关键非必需氨基酸合成供碳/氮。
  • GLS1抑制剂CB-839可下调I级脑膜瘤谷氨酰胺代谢通路并减少增殖。

核心结论

  • 丙氨酸和谷氨酰胺/谷氨酸主要在II级脑膜瘤中升高。
  • I级脑膜瘤具有相对较高的谷氨酰胺代谢,为关键非必需氨基酸生物合成提供碳/氮。
  • GLS1抑制剂CB-839能有效下调I级脑膜瘤谷氨酰胺代谢通路,导致细胞增殖减少。

研究设计与样本

  • 对脑膜瘤患者肿瘤组织行1H NMR光谱分析,以区分I级和II级脑膜瘤的代谢物谱。
  • 在5例患者来源脑膜瘤细胞中,用13C/15N谷氨酰胺示踪检测谷氨酰胺代谢。

主要发现

  • 丙氨酸、乳酸、谷氨酸、谷氨酰胺和甘氨酸仅在II级脑膜瘤中分别升高74%、76%、35%、75%和33%。
  • 丙氨酸和谷氨酰胺水平具统计学显著性(P≤.02)。
  • 13C/15N谷氨酰胺示踪显示I级和II级脑膜瘤均活跃代谢谷氨酰胺,生成丙氨酸和脯氨酸等肿瘤生长所需关键碳中间体。
  • GLS1抑制剂CB-839在脑膜瘤细胞中高度有效地下调谷氨酰胺代谢并减少增殖。

临床怎么用

  • II级脑膜瘤中丙氨酸和谷氨酰胺/谷氨酸升高,可作为代谢表型区分参考。
  • I级脑膜瘤谷氨酰胺代谢活跃,支持谷氨酰胺回补为氨基酸合成供能供料。
  • GLS1抑制剂CB-839在患者来源脑膜瘤细胞中显示下调谷氨酰胺代谢和抗增殖效果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: We postulate that meningiomas undergo distinct metabolic reprogramming in tumorigenesis and unraveling their metabolic phenotypes provide new therapeutic insights. Glutamine catabolism is key to the growth and proliferation of tumors. Here, we investigated the metabolomics of freshly resected meningiomas and glutamine metabolism in patient-derived meningioma cells. METHODS: 1H NMR spectroscopy of tumor tissues from meningioma patients was used to differentiate the metabolite profiles of grade-I and grade-II meningiomas. Glutamine metabolism was examined using 13C/15N glutamine tracer, in 5 patient-derived meningioma cells. RESULTS: Alanine, lactate, glutamate, glutamine, and glycine were predominantly elevated only in grade-II meningiomas by 74%, 76%, 35%, 75%, and 33%, respectively, with alanine and glutamine levels being statistically significant (P ≤ .02). 13C/15N glutamine tracer experiments revealed that both grade-I and -II meningiomas actively metabolize glutamine to generate various key carbon intermediates including alanine and proline that are necessary for the tumor growth. Also, it is shown that glutaminase (GLS1) inhibitor, CB-839 is highly effective in downregulating glutamine metabolism and decreasing proliferation in meningioma cells. CONCLUSION: Alanine and glutamine/glutamate are mainly elevated in grade-II meningiomas. Grade-I meningiomas possess relatively higher glutamine metabolism providing carbon/nitrogen for the biosynthesis of key nonessential amino acids. GLS1 inhibitor (CB-839) is very effective in downregulating glutamine metabolic pathways in grade-I meningiomas leading to decreased cellular proliferation.

来源:Neuro Oncol,查看原文。版权归原作者所有。

引用

  1. Ijare OB, Hambarde S, Brasil da Costa FH, et al. Glutamine anaplerosis is required for amino acid biosynthesis in human meningiomas. Neuro Oncol. 2022. PMID: 34515312. doi:10.1093/neuonc/noab219

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。